News
Biohaven Ltd. (NYSE:BHVN) is one of the best small cap stocks with biggest upside potential. On August 12, Leerink lowered ...
Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...
23h
TipRanks on MSNBiohaven Ltd. Awaits FDA Decision on Troriluzole
The latest announcement is out from Biohaven Ltd. ( (BHVN) ).
Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...
Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.
On a very good Friday for the stock market, Biohaven 's (NYSE: BHVN) performance was exceptional. The clinical-stage biotech 's share price inflated by over 6% that trading session thanks to ...
In a report released on August 15, William Pickering from Bernstein maintained a Buy rating on Biohaven Ltd., with a price target of $34.00. The company’s shares closed last Friday at $15.71. Take ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Investing.com -- Biohaven Ltd. (NYSE: BHVN) stock rose 3% Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) no longer plans to hold an advisory committee ...
The latest update is out from Biohaven Ltd. ( (BHVN) ).
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results